In a rare occurrence worldwide, the CK Birla Hospital® treats 32-year-old woman for a giant mesenteric tumour via complex laparoscopic surgery
Subject Expert Committee(SEC) of Central Drugs Standard Control Organization (CDSCO)
First and only PARP inhibitor to improve invasive disease-free survival, the primary endpoint, and overall survival, a key secondary endpoint of the OlympiA trial, in these patients
3D CMOS chip for connecting electroactive tissues and organoids to software
Lynparza is the first and only approved PARPi targeting BRCA-mutated HER2-negative high-risk early breast cancer
Man lost 54 Kgs in 6 months with MGB procedure
Use of IVUS recommended in all phases of lower extremity arterial and venous revascularization procedures to guide clinical decisions
Pfizer plans to submit an sBLA by the end of this year, subject to discussions with U.S. FDA
First and only PARP inhibitor to improve invasive disease-free survival, the primary endpoint, and overall survival, a key secondary endpoint, in these patients
Capnomed successfully introduced the medical device Capnopen, the gold standard of laparoscopic nebulizers.
Subscribe To Our Newsletter & Stay Updated
